These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30889588)

  • 1. Rate of Serious Adverse Events Associated with Diazoxide Treatment of Patients with Hyperinsulinism.
    Thornton P; Truong L; Reynolds C; Hamby T; Nedrelow J
    Horm Res Paediatr; 2019; 91(1):25-32. PubMed ID: 30889588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide.
    Herrera A; Vajravelu ME; Givler S; Mitteer L; Avitabile CM; Lord K; De León DD
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4365-4372. PubMed ID: 30247666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of pulmonary hypertension in an infant treated with diazoxide.
    Nebesio TD; Hoover WC; Caldwell RL; Nitu ME; Eugster EA
    J Pediatr Endocrinol Metab; 2007 Aug; 20(8):939-44. PubMed ID: 17937066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism.
    Brar PC; Heksch R; Cossen K; De Leon DD; Kamboj MK; Marks SD; Marshall BA; Miller R; Page L; Stanley T; Mitchell D; Thornton P
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32810255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension and reopening of the ductus arteriosus in an infant treated with diazoxide.
    Demirel F; Unal S; Çetin II; Esen I; Arasli A
    J Pediatr Endocrinol Metab; 2011; 24(7-8):603-5. PubMed ID: 21932611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment.
    Davidov AS; Elkon-Tamir E; Haham A; Shefer G; Weintrob N; Oren A; Lebenthal Y; Mandel D; Eyal O
    Eur J Pediatr; 2020 Apr; 179(4):597-602. PubMed ID: 31863303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria.
    Touati G; Poggi-Travert F; Ogier de Baulny H; Rahier J; Brunelle F; Nihoul-Fekete C; Czernichow P; Saudubray JM
    Eur J Pediatr; 1998 Aug; 157(8):628-33. PubMed ID: 9727845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: A systematic review and meta-analysis.
    Chen X; Feng L; Yao H; Yang L; Qin Y
    PLoS One; 2021; 16(2):e0246463. PubMed ID: 33571197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necrotizing Enterocolitis in Neonates With Hyperinsulinemic Hypoglycemia Treated With Diazoxide.
    Keyes ML; Healy H; Sparger KA; Orth LE; Geha M; Roumiantsev S; Matute JD
    Pediatrics; 2021 Feb; 147(2):. PubMed ID: 33483452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia and neutropenic fever with high dose diazoxide treatment in a case with hyperinsulinism due to Munchausen by proxy.
    Ozon A; Demirbilek H; Ertugrul A; Unal S; Gumruk F; Kandemir N
    J Pediatr Endocrinol Metab; 2010 Jul; 23(7):719-23. PubMed ID: 20857844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy.
    Yildizdas D; Erdem S; Küçükosmanoglu O; Yilmaz M; Yüksel B
    Adv Ther; 2008 May; 25(5):515-9. PubMed ID: 18512033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review.
    Timlin MR; Black AB; Delaney HM; Matos RI; Percival CS
    Pediatr Cardiol; 2017 Aug; 38(6):1247-1250. PubMed ID: 28642988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Hypertension Following Increased Dosing of Diazoxide in an Infant.
    Ohnishi Y; Okada S; Yasudo H; Kimura S; Suzuki Y; Hasegawa S
    Int Heart J; 2020 Sep; 61(5):1084-1087. PubMed ID: 32921661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the duration of treatment with diazoxide in infants with prolonged hyperinsulinism (PHI).
    Raisingani M; Brar PC
    J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1241-1245. PubMed ID: 31465295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver injury may increase the risk of diazoxide toxicity: a case report.
    Tas E; Mahmood B; Garibaldi L; Sperling M
    Eur J Pediatr; 2015 Mar; 174(3):403-6. PubMed ID: 25618267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in management of transient hyperinsulinism - a retrospective analysis of 36 severely affected children.
    Hoermann H; Roeper M; Salimi Dafsari R; Koestner F; Reinauer C; Mayatepek E; Meissner T; Kummer S
    J Pediatr Endocrinol Metab; 2021 Jul; 34(7):867-875. PubMed ID: 33860651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom.
    Chen SC; Dastamani A; Pintus D; Yau D; Aftab S; Bath L; Swinburne C; Hunter L; Giardini A; Christov G; Senniappan S; Banerjee I; Shaikh MG; Shah P
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):770-775. PubMed ID: 31520536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of diazoxide with frusemide, spironolactone, and acetylsalicylic acid in a patient with hyperinsulinism of Infancy and Fallot tetralogy.
    Alexander S; Anazodo A; Hussain K
    Eur J Pediatr; 2003 Nov; 162(11):806-7. PubMed ID: 13680383
    [No Abstract]   [Full Text] [Related]  

  • 19. Complications of diazoxide treatment in persistent neonatal hyperinsulinism.
    Abu-Osba YK; Manasra KB; Mathew PM
    Arch Dis Child; 1989 Oct; 64(10):1496-500. PubMed ID: 2684032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Insufficiency Caused by Diazoxide in a Premature Neonate with Congenital Hyperinsulinism.
    Okada S; Fukunaga S; Ohta H; Furuta T; Hirano R; Motonaga T; Ishikawa Y
    Neuropediatrics; 2020 Jun; 51(3):211-214. PubMed ID: 31777044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.